Showing results (1791-1800 of 1,972) with videos related to

Sort By:
Pageof 198
Hepatology Communications|April 30, 2025
Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction-associated steatotic liver diseaseAlina M Allen, Jeffrey V Lazarus, Naim Alkhouri, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 4, 2019
Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus InfectionZobair M Younossi, Maria Stepanova, Andrei Racila, et al.
Molecular Biology of the Cell|August 18, 2006
Mammalian CLASP1 and CLASP2 cooperate to ensure mitotic fidelity by regulating spindle and kinetochore functionAna L Pereira, António J Pereira, Ana R R Maia, et al.
BMC Medicine|September 13, 2018
An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver diseaseZobair M Younossi, Azza Karrar, Mariaelena Pierobon, et al.
Science Advances|October 25, 2016
Robotic QM/MM-driven maturation of antibody combining sitesIvan V Smirnov, Andrey V Golovin, Spyros D Chatziefthimiou, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 21, 2018
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled studyMaria Stepanova, Fatema Nader, Christophe Bureau, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|September 3, 2004
[Plasminogen activator of urokinase-type: mechanisms of involvement in vessel remodeling and angiogenesis, gene therapy approaches to ischemia]E V Parfenova, V V Plekhanova, V V Stepanova, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|July 3, 2009
[Penetrating peptide inhibitor of the myosin light chain kinase suppresses hyperpermeability of vascular endothelium]A V Marchenko, M V Sidorova, A V Sekridova, et al.
Plos One|April 6, 2021
BH4-deficient hyperphenylalaninemia in RussiaPolina Gundorova, Irina A Kuznetcova, Galina V Baydakova, et al.
Blood Pressure|November 25, 2025
Is primary aldosteronism a frequent form of hypertension? Data from the Czech Registry and the Czech Institute of Health Information and StatisticsJiri Widimsky, Thi Minh Phuong Nikrynova Nguyen, Zdenek Ramik, et al.
Pageof 198